Wall Street Thinks This Biotech Stock Could Soar 57%
Biotech investing often rides on data, not on dreams. This educational piece uses a fictional company to show how wal...
Why choose index funds over active funds? Because broad diversification, lower costs, and proven long-term results often beat active management.
26,956 articlesBiotech investing often rides on data, not on dreams. This educational piece uses a fictional company to show how wal...
Jamie Dimon has warned that certain stablecoin rules could destabilize financial markets. This article breaks down th...
AI-driven demand and memory shortages could propel Micron to new highs by late 2027. This article lays out why a big ...
NVIDIA is set to report fiscal Q4 2026 results after the close on February 25, 2026. Street expectations point to a b...
Salesforce unveiled a $50 billion buyback and a new AI metric, but traders remain wary that AI disruption could erode...
Nebius Group wins approval to build a 1.2 GW AI factory in Independence, Missouri, signaling a major shift in U.S. AI...
Investors are watching codexis (CDXS) 2025 earnings closely to see if partnerships and enzyme platforms translate int...
Oil and currency markets tremble as new Iran-related tensions top the global agenda. Asia, with its export-led growth...
A hypothetical $1,000 XRP bet on election night would have endured wild swings and sharp turns. Here’s the latest rea...
Piper Sandler just hiked Humana's price target to $254 after a strong Q1 and improving Medicare Advantage margins, si...
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
AMD is riding a surge in AI-centric demand that could push its stock higher, even as it faces the same repricing pres...